Active form of prodrug: Monomethyl fumarate [DR:D11492]
Treatment of relapsing remitting multiple sclerosis.
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AX Other immunosuppressants
L04AX10 Tegomil fumarate
D13167 Tegomil fumarate (INN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D13167
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D13167